Key result
Worsening kidney function is not independently linked to 1-year death or heart failure worsening.
Why the study?
Kidney dysfunction is common in chronic heart failure, but its prognostic significance in contemporary populations remains uncertain.
Does kidney dysfunction independently predict worsening heart failure and mortality at 1 year in a contemporary ambulatory heart failure cohort?
Cohort (n=1,105)
Yes
Does kidney dysfunction independently predict worsening heart failure and mortality at 1 year in a contemporary ambulatory heart failure cohort?
p-value: p=<.001
In contemporary ambulatory heart failure patients, worse kidney function marks a more adverse clinical profile but loses independent association with a composite of death or worsening HF after adjusting for congestion and severity markers, while retaining independent prognostic value for all-cause mortality.
Introduction and objectives Kidney dysfunction is common in chronic heart failure (CHF), but its prognostic significance in contemporary populations remains uncertain. We evaluated 1-year outcomes according to kidney function stage and the prognostic role of the estimated glomerular filtration rate (eGFR). Methods We analyzed 1105 patients with CHF enrolled in the CARDIOREN Registry (13 centers, 2021-2022). Kidney function was categorized according to CKD-EPI eGFR (≥ 60, 30-59, < 30 mL/min/1.73 m 2 ). The primary endpoint was the composite of all-cause death or worsening heart failure at 1 year; all-cause mortality was analyzed separately. Associations were assessed using multivariable Cox regression models with fractional polynomial modeling. Results Median age was 75 years, 63% of patients were men, and 38% had heart failure with preserved ejection fraction. Overall, 59% had eGFR < 60 mL/min/1.73 m 2 . At 1 year, the composite endpoint occurred in 24% of patients, and all-cause mortality occurred in 13%. Event rates increased progressively with worsening kidney function categories for the primary endpoint (11%, 31%, and 38%; P < .001) and for all-cause mortality (4%, 16%, and 26%; P < . 001). In multivariable analysis, N-terminal pro-B-type natriuretic peptide, hemoglobin, and furosemide-equivalent dose were independently associated with both outcomes. Hemoglobin showed a U-shaped association, with higher risk at both low and high concentrations. CA125 was independently associated with all-cause mortality. eGFR was not independently associated with the composite endpoint but remained independently associated with all-cause mortality, showing a nonlinear inverse relationship. Conclusions In this contemporary CHF population, worse kidney function identified patients with a more adverse clinical profile and poorer outcomes, although these associations were attenuated after adjustment for congestion markers and disease severity.
No takes yet. Share an insight, caveat, or question.
Marcos et al. (2026) conducted a cohort in Chronic heart failure (CHF) (n=1,105). Worsening kidney function (eGFR categories) vs. eGFR ≥ 60 mL/min/1.73 m2 was evaluated on Composite of all-cause death or worsening heart failure at 1 year (p=<.001). Worsening kidney function was associated with higher 1-year rates of death or worsening heart failure (11%, 31%, 38%; P<.001), though not independently associated after multivariable adjustment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: